Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Susan G.R. McDuff"'
Autor:
Colin D. Weekes, James C. Cusack, Christine E. Eyler, Lipika Goyal, Jochen K. Lennerz, Emily E. Van Seventer, Jill N. Allen, Jennifer Y. Wo, Peter J. Ulintz, Andrew X. Zhu, Hui Zheng, Susan G.R. McDuff, Theodore S. Hong, Daniel Kim, David P. Ryan, Mehlika Hazar-Rethinam, Jeffrey W. Clark, Ryan B. Corcoran, Isobel J Fetter, Brandon Nadres, Lawrence S. Blaszkowsky, Aparna Raj Parikh, Karin M. Hardiman
Publikováno v:
JCO Precis Oncol
PURPOSE This study was designed to assess the ability of perioperative circulating tumor DNA (ctDNA) to predict surgical outcome and recurrence following neoadjuvant chemoradiation for locally advanced rectal cancer (LARC). MATERIALS AND METHODS Twen
Autor:
Yasamin Sharifzadeh, Kevin X. Liu, Parag Sanghvi, Daniel R. Simpson, Tonya M Pan-Weisz, Ronghui Xu, Susan G.R. McDuff, M.A. Salans, Jona A. Hattangadi-Gluth, Euyhyun Lee, Jeffrey Burkeen, Yoseph Dalia, Carrie R. McDonald, Deborah C. Marshall, Anthony Yip
Publikováno v:
Am J Clin Oncol
Objective We conducted a prospective clinical trial of patients receiving radiation (RT) for brain metastases to identify clinical predictors of pre-RT and post-RT health-related quality of life (hrQoL). Materials and methods Patients with brain meta
Autor:
E. Shelley Hwang, Rachel A. Greenup, Caitlin E. Marks, Yi Ren, Susan G.R. McDuff, Jennifer K. Plichta, Samantha M. Thomas, Laura H. Rosenberger, Oluwadamilola M. Fayanju, Gretchen Kimmick
Publikováno v:
J Surg Res
BACKGROUND: Elderly women with clinically node-positive (cN+) breast cancer (BC) often have comorbidities that limit life expectancy and complicate treatment. We sought to determine whether the number of lymph nodes (LNs) retrieved among older women
Autor:
Jay S. Loeffler, Susan G.R. McDuff, Jorg Dietrich, Helen A. Shih, Katelyn M. Atkins, Kevin S. Oh
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 3-11 (2020)
Cancer Medicine
Cancer Medicine
Purpose The majority of patients with high‐risk lower grade gliomas (LGG) are treated with single‐agent temozolomide (TMZ) and radiotherapy despite three randomized trials showing a striking overall survival benefit with adjuvant procarbazine, lo
Publikováno v:
Current Breast Cancer Reports. 11:203-216
Immune checkpoint blockade (ICB) is an emerging therapy in breast cancer. Its optimal integration with radiation therapy (RT) for breast cancer remains to be established. Herein, we review the current evidence on combining ICB and RT in breast cancer
Autor:
Hoda E. Sayegh, Meyha N. Swaroop, Amir I. Mina, George E. Naoum, Melissa N. Skolny, Kayla M. Daniell, Tessa C Gillespie, Laura Salama, Susan G.R. McDuff, Maria S. Asdourian, Laura E.G. Warren, Hui Zheng, Cheryl L. Brunelle, Mohamed Abouegylah, Alphonse G. Taghian
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 103:62-70
Purpose The purpose of the study was to determine when the risk of lymphedema is highest after treatment of breast cancer and which factors influence the time course of lymphedema development. Methods and Materials Between 2005 and 2017, 2171 women (
Autor:
Susan G.R. McDuff, Sua Yoo, Suzanne Catalano, Rachel C. Blitzblau, Jay Morrison, Colin E. Champ, Fang-Fang Yin, Q. Jackie Wu, L. O'Neill, Yang Sheng
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100656-(2021)
Advances in Radiation Oncology
Advances in Radiation Oncology
Purpose: The machine learning–based automated treatment planning (MLAP) tool has been developed and evaluated for breast radiation therapy planning at our institution. We implemented MLAP for patient treatment and assessed our clinical experience f
Autor:
Susan G.R. McDuff, Jennifer R. Bellon, Alice Y. Ho, Michele A. Gadd, Samantha A. Dunn, Barry S. Rosenstein, Kristen M. Shannon
Publikováno v:
International journal of radiation oncology, biology, physics. 110(5)
Purpose Advances in germline genetic testing have led to a surge in identification of ataxia-telangiectasia mutated (ATM) variant carriers among breast cancer patients, raising numerous questions regarding use of breast radiation therapy (RT) in this
Autor:
Laura H. Rosenberger, Susan G.R. McDuff, Rachel A. Greenup, E. Shelley Hwang, Jeremy Force, Jennifer K. Plichta, Yi Ren, Caitlin E. Marks, Samantha M. Thomas, Oluwadamilola M. Fayanju
Publikováno v:
Ann Surg Oncol
BACKGROUND. Men represent a small proportion of breast cancer diagnoses, and they are often excluded from clinical trials. Current treatments are largely extrapolated from evidence in women. We compare practice patterns between men and women with bre
Publikováno v:
Annals of palliative medicine. 10(5)
Metastatic breast cancer has traditionally been considered incurable, with treatments focused on systemic therapies and palliative local treatment. However, evidence is emerging that in some patients with limited metastatic disease, or "oligometastat